Literature DB >> 21543468

Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.

Qiong-Ying Hu1, Elizabeth Fink, Meaghan Happer, John H Elder.   

Abstract

Heparan sulfate proteoglycans (HSPGs) act as binding receptors or attachment factors for the viral envelope of many viruses, including strains of HIV and feline immunodeficiency virus (FIV). The FIV gp95 glycoprotein (SU) from laboratory-adapted strains (tissue culture adapted [TCA]) such as FIV-34TF10 can bind to HSPG, whereas SU from field strains (FS) such as FIV-PPR cannot. Previous studies indicate that SU-HSPG interactions occur within the V3 loop. We utilized a series of nested V3 peptides to further map the HSPG binding sites and found that both sides of the predicted V3 loop stem were critical for the binding but not the CXCR4 binding domain near the predicted tip of the V3 loop. Neutralization assays for TCA strain entry using the same set of V3 peptides showed that peptides targeting CXCR4 or HSPG binding sites can block infection, supporting the V3 loop as a critical neutralization target. Site-directed mutagenesis identified two highly conserved arginines, R379 and R389, on the N-terminal side of the V3 stem as critical for the contact between SU and HSPG. Residues K407, K409, K410, and K412 on the C-terminal side of the V3 stem form a second nonconserved domain necessary for HSPG binding, consistent with the observed specificity distinctions with FS FIV. Our findings discriminate structural determinants important for HSPG and CXCR4 binding by FIV SU and thus further define the importance of the V3 loop for virus entry and infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543468      PMCID: PMC3126603          DOI: 10.1128/JVI.00573-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

Review 1.  Specificities of heparan sulphate proteoglycans in developmental processes.

Authors:  N Perrimon; M Bernfield
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

2.  Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120.

Authors:  M Moulard; H Lortat-Jacob; I Mondor; G Roca; R Wyatt; J Sodroski; L Zhao; W Olson; P D Kwong; Q J Sattentau
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells.

Authors:  D L Lerner; J H Elder
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.

Authors:  A de Parseval; J H Elder
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes.

Authors:  P Hilgard; R Stockert
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

Review 6.  Heparan sulfate: anchor for viral intruders?

Authors:  D Spillmann
Journal:  Biochimie       Date:  2001-08       Impact factor: 4.079

7.  Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages.

Authors:  A C Saphire; M D Bobardt; Z Zhang; G David; P A Gallay
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.

Authors:  Qiong-Ying Hu; Elizabeth Fink; Yang Hong; Cathy Wang; Chris K Grant; John H Elder
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

9.  A turn-like structure "KKPE" segment mediates the specific binding of viral protein A27 to heparin and heparan sulfate on cell surfaces.

Authors:  Ping-Chen Shih; Min-Shiang Yang; Su-Ching Lin; Yu Ho; Jye-Chian Hsiao; Da-Rong Wang; Steve S-F Yu; Wen Chang; Der-Lii M Tzou
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

10.  Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35.

Authors:  Sebastian Tuve; Hongjie Wang; Jeffrey D Jacobs; Roma C Yumul; David F Smith; André Lieber
Journal:  PLoS Pathog       Date:  2008-10-31       Impact factor: 6.823

View more
  9 in total

1.  Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells.

Authors:  Md Nasimuzzaman; Derek A Persons
Journal:  Mol Ther       Date:  2012-03-20       Impact factor: 11.454

2.  Transmembrane TNF-α Facilitates HIV-1 Infection of Podocytes Cultured from Children with HIV-Associated Nephropathy.

Authors:  Jinliang Li; Jharna R Das; Pingtao Tang; Zhe Han; Jyoti K Jaiswal; Patricio E Ray
Journal:  J Am Soc Nephrol       Date:  2016-11-03       Impact factor: 10.121

3.  Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.

Authors:  Qiong-Ying Hu; Elizabeth Fink; John H Elder
Journal:  Retrovirology (Auckl)       Date:  2012-07-11

4.  Replacement of the V3 domain in the surface subunit of the feline immunodeficiency virus envelope glycoprotein with the equivalent region of a T cell-tropic human immunodeficiency virus type 1 results in a chimeric surface protein that efficiently binds to CXCR4.

Authors:  Silvia A González; Juan I Falcón; José L Affranchino
Journal:  AIDS Res Hum Retroviruses       Date:  2013-11-12       Impact factor: 2.205

5.  Mutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission.

Authors:  Benjamin G Luttge; Prashant Panchal; Vinita Puri; Mary Ann Checkley; Eric O Freed
Journal:  Biochim Biophys Acta       Date:  2013-09-10

Review 6.  The molecular biology of feline immunodeficiency virus (FIV).

Authors:  Julia C Kenyon; Andrew M L Lever
Journal:  Viruses       Date:  2011-11-09       Impact factor: 5.048

Review 7.  Pharmacological inhibition of feline immunodeficiency virus (FIV).

Authors:  Hakimeh Mohammadi; Dorothee Bienzle
Journal:  Viruses       Date:  2012-04-27       Impact factor: 5.048

8.  Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virus.

Authors:  Qiong-Ying Hu; Elizabeth Fink; Chris K Grant; John H Elder
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

Review 9.  Sulfated Glycans and Related Digestive Enzymes in the Zika Virus Infectivity: Potential Mechanisms of Virus-Host Interaction and Perspectives in Drug Discovery.

Authors:  Vitor H Pomin
Journal:  Interdiscip Perspect Infect Dis       Date:  2017-01-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.